Drug Shortage Report for VITAMIN K1
Report ID | 113624 |
Drug Identification Number | 00781878 |
Brand name | VITAMIN K1 INJ 1MG/0.5ML USP |
Common or Proper name | VITAMIN K1 INJ 2MG/0.5 ML |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | VITAMIN K1 |
Strength(s) | 2MG |
Dosage form(s) | EMULSION |
Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
Packaging size | 10MG/ML |
ATC code | B02BA |
ATC description | VITAMIN K AND OTHER HEMOSTATICS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2020-05-01 |
Estimated end date | 2020-05-08 |
Actual end date | 2020-05-07 |
Shortage status | Resolved |
Updated date | 2020-05-12 |
Company comments | Release delay at manufacturing site. Product had been placed on allocation at 50% of historical usage. Alternative product 9110 VITAMIN K1 INJ 10MG/ML remains available and is on protective allocation at 125% of historical usage. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-05-12 | French | Compare |
v4 | 2020-05-12 | English | Compare |
v3 | 2020-05-02 | English | Compare |
v2 | 2020-05-01 | French | Compare |
v1 | 2020-05-01 | English | Compare |
Showing 1 to 5 of 5